The Ribonucleoprotein (RNP) Complex

At AGS, our drug discovery platform focuses on an under-explored drug target, the ribonucleoprotein (RNP) complex. Targeting RNPs is challenging due to the multiple roles, dynamic conformations, and chemical instability of these complexes. To address this challenge, we have developed a robust cell-based screening platform dedicated to targeting these complexes.